BIOMARKER COMPOSITION FOR DIAGNOSING MASSIVE PERIVILLOUS FIBRIN DEPOSITION AND USE THEREOF

摘要

The present invention relates to a biomarker composition for diagnosing abortion placental fibrin hyperdeposition and uses thereof. The protein included as an active ingredient in the biomarker composition for diagnosing abortion placental fibrin hyperdeposition according to the present invention is specifically found only in the blood of mothers diagnosed with fibrin-type MPFD (f-MPFD), so it is useful for diagnosis with f-MPFD. It can be utilized and can prevent habitual miscarriage according to f-MPFD in advance. In addition, through the MPFD diagnosis, there is an opportunity to detect MPFD-related blood hypercoagulation disease in advance by additionally examining the MPFD-related blood hypercoagulation disease in mothers diagnosed with MPFD, and it is possible to prevent and treat serious complications caused by the blood hypercoagulation disease.